UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality of life in patients with vertebral fractures : Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO)

Osteoporosis international, 1999-08, Vol.10 (2), p.150-160

1999

Volltextzugriff (PDF)

MANAGEMENT OF ENDOCRINE DISEASE: Therapeutics of Vitamin D

European journal of endocrinology, 2018-11, Vol.179 (5), p.R239-R259

2018

Volltextzugriff (PDF)

Treatment failure in osteoporosis

Osteoporosis international, 2012-12, Vol.23 (12), p.2769-2774

2012

Volltextzugriff (PDF)

Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes

Journal of endocrinology, 2002-06, Vol.173 (3), p.525-532

2002

Volltextzugriff (PDF)

Hip and non-spine fracture risk reductions differ among antiresorptive agents: evidence from randomised controlled trials

International journal of clinical practice (Esher), 2006-11, Vol.60 (11), p.1394-1400

2006

Volltextzugriff (PDF)

Vitamin D enhances caspase-dependent and independent TNF-induced breast cancer cell death: the role of reactive oxygen species

Annals of the New York Academy of Sciences, 2003-12, Vol.1010 (1), p.437-440

2003

Volltextzugriff (PDF)

Taxonomy of rare genetic metabolic bone disorders

Osteoporosis international, 2015-10, Vol.26 (10), p.2529-2558

2015

Volltextzugriff (PDF)

Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials

Osteoporosis international, 2012-01, Vol.23 (1), p.233-245

2012

Volltextzugriff (PDF)

Erratum to: Taxonomy of rare genetic metabolic bone disorders

Osteoporosis international, 2015-11, Vol.26 (11), p.2717-2718

2015

Volltextzugriff (PDF)

Upregulation of the calcium-dependent protease, calpain, during keratinocyte differentiation

British journal of dermatology (1951), 1998-12, Vol.139 (6), p.950-957

1998

Volltextzugriff (PDF)

Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease

Pediatrics (Evanston), 1994-09, Vol.94 (3), p.385-389

1994

Volltextzugriff (PDF)

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

The New England journal of medicine, 1995-11, Vol.333 (22), p.1437-1444

1995

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (4), p.862-867

1999

Volltextzugriff (PDF)

1,25-dihydroxyvitamin D3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cells

Journal of endocrinology, 1996-05, Vol.149 (2), p.327-333

1996

Volltextzugriff (PDF)

Vitamin D is a prooxidant in breast cancer cells

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (4), p.1439-1444

2001

Volltextzugriff (PDF)

Hypoparathyroidism-a long-term follow-up experience with 1α-vitamin D3 therapy

Clinical endocrinology (Oxford), 1994-03, Vol.40 (3), p.303-307

1994

Volltextzugriff (PDF)

Hereditary hypophosphatemic rickets with hypercalciuria

The New England journal of medicine, 1985-03, Vol.312 (10), p.611-617

1985

Volltextzugriff (PDF)

Response to Boonen et al. 'Assessing the relative efficacy of different osteoporosis agents based on the outcomes from meta-analyses'

International journal of clinical practice (Esher), 2008-01, Vol.62 (1), p.165-166

2008

Volltextzugriff (PDF)

A new kindred with hereditary hypophosphatemic rickets with hypercalciuria: implications for correct diagnosis and treatment

Nephron (2015), 1992, Vol.62 (2), p.176-181

1992

Volltextzugriff (PDF)

Incidence of Nonvertebral Fractures in Relation to Time on Treatment and Bone Density in Glucocorticoid-Treated Patients: A Retrospective Approach

Journal of clinical rheumatology, 2003-06, Vol.9 (3), p.170-175

2003

Volltextzugriff (PDF)

1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells

Molecular and cellular endocrinology, 1993-10, Vol.96 (1-2), p.133-139

1993

Volltextzugriff (PDF)

Vitamin D–Resistant Diseases

Journal of bone and mineral research, 2007-12, Vol.22 (S2), p.V105-V107

Liberman, Uri A

2007

Volltextzugriff (PDF)

Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D

The Journal of clinical investigation, 1985-11, Vol.76 (5), p.2012-2015

1985

Volltextzugriff (PDF)

Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor

The Journal of clinical investigation, 1989-06, Vol.83 (6), p.2093-2101

1989

Volltextzugriff (PDF)

Effectiveness of Difluprednate for the Treatment of Anterior Scleritis

American journal of ophthalmology, 2022-03, Vol.235, p.172-177

2022

Volltextzugriff (PDF)

1 – 25 von 251

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(123)
Humans
(117)
Biological And Medical Sciences
(70)
Female
(61)
Male
(49)
Medical Sciences
(41)
Endocrinology & Metabolism
(30)
Calcitriol - Pharmacology
(29)
Fundamental And Applied Biological Sciences. Psychology
(29)
Middle Aged
(28)
Animals
(25)
General & Internal Medicine
(24)
Aged
(21)
Mathematical & Computational Biology
(21)
Physical Sciences
(21)
Adult
(20)
Models, Genetic
(20)
Medicine, General & Internal
(19)
Vitamin D
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality of life in patients with vertebral fractures : Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO)

MANAGEMENT OF ENDOCRINE DISEASE: Therapeutics of Vitamin D

Treatment failure in osteoporosis

Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes

Hip and non-spine fracture risk reductions differ among antiresorptive agents: evidence from randomised controlled trials

Vitamin D enhances caspase-dependent and independent TNF-induced breast cancer cell death: the role of reactive oxygen species

Taxonomy of rare genetic metabolic bone disorders

Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials

Erratum to: Taxonomy of rare genetic metabolic bone disorders

Upregulation of the calcium-dependent protease, calpain, during keratinocyte differentiation

Aminohydroxy propylidene bisphosphonate (APD) treatment improves the clinical skeletal manifestations of Gaucher's disease

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1,25-dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage

1,25-dihydroxyvitamin D3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor alpha but not to interferon alpha or lymphokine-activated killer cells

Vitamin D is a prooxidant in breast cancer cells

Hypoparathyroidism-a long-term follow-up experience with 1α-vitamin D3 therapy

Hereditary hypophosphatemic rickets with hypercalciuria

Response to Boonen et al. 'Assessing the relative efficacy of different osteoporosis agents based on the outcomes from meta-analyses'

A new kindred with hereditary hypophosphatemic rickets with hypercalciuria: implications for correct diagnosis and treatment

Incidence of Nonvertebral Fractures in Relation to Time on Treatment and Bone Density in Glucocorticoid-Treated Patients: A Retrospective Approach

1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells

Vitamin D–Resistant Diseases

Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D

Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor

Effectiveness of Difluprednate for the Treatment of Anterior Scleritis

Suchergebnisse filtern